PR Newswire BiotechOriginal article
CordenPharma Boosts Aseptic Fill-Finish Capacity to 500 Million Sterile Injectable Units Per Year
Positive
AI Analysis
Summary
CordenPharma announced an €80 million multi-year investment to expand its aseptic fill-finish capacity to 500 million sterile injectable units per year, including construction of new facilities and additional production lines.
Importance:3/10
Sentiment:
0.60
capacity expansionCDMOaseptic fill-finishsterile injectablesmanufacturingcapital investment
Related Companies
Read the original article
Published by PR Newswire Biotech on September 10, 2026 5:30 AM